These innovative medications , Tirzepatide , represent a groundbreaking advancement in addressing metabolic dysfunction and possibly related ailments . They all are classified as GLP-1 pathway stimulators, indicating they function to replicate the natural GLP-1 peptide, enhancing metabolic produc